Latest News
World Antimicrobial Awareness Week 2020 (WAAW; 18–24 November) is upon us. Infectious Diseases Hub takes a look at the past,…
Just 1 week after Pfizer and BioNTech’s early Phase III trial data were released, more good news comes from Moderna’s…
The first set of data from Pfizer (NY, USA) and BioNTech’s (Mainz, Germany) Phase III clinical trial for their COVID-19…
Journal Articles
Short Communication article on the divergence between SARS-CoV-2 and RaTG13, published as part of the Special Focus Issue on the COVID-19 pandemic in Future Virology
Infectious Diseases Hub has partnered with Future Virology to bring you exclusive access to articles and features in the recent Special Focus Issue.
In this Commentary article published in the Special Focus Issue in Future Virology on the COVID-19 pandemic, researchers study the safety of different populations in regard to the spread of disease.
Bacterial
Antimicrobials: handle with care
Application of bacteriophages to overcome antimicrobial resistance
Clostridium Difficile Infection
How can bacterial toxins evolve to infect different tissues?
Could RBX2660 be the microbiome-based solution to C. diff infection recurrence?
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
E. Coli
Antibodies from maternal microbiota could protect newborns from infection
Multidrug efflux systems: information on evolution and mechanisms uncovered
E. coli created with world’s first synthetic and redesigned genome
H. Pylori
Organoids: a new model to study infectious diseases?
MRSA
The race for COVID-19 treatments and vaccines: February’s industry headlines
New study reveals how the household environment influences MRSA spread
Novel vaccine candidate for Staphylococcus aureus shows 80% efficacy in mice
Salmonella
Application of bacteriophages to overcome antimicrobial resistance
Novel models for enteric infections – an interview with the Faherty Lab
Tuberculosis
Countries with previous TB vaccine coverage show improved COVID-19 outcomes
The role of humoral immunity in TB defense – an interview with Babak Javid
Changing the administration of the BCG vaccine could improve efficacy
Fungal
A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi
The best of 2019 – an A–Z of infectious diseases research
A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals
Aspergillosis
Fungal biofilm morphology impacts disease progression
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Novel antifungal presents opportunities for treating aspergillosis
Candidiasis
A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi
A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals
Could climate change have contributed to Candida auris emergence?
Coccidioidomycosis
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Identification of membrane proteome of Paracoccidioides lutzii and its regulation by zinc
Cryptococcal Meningitis
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Parasitic
Malaria parasites resistant to artemisinin now prevalent in Africa
Using a novel approach for malaria vaccine development – an interview with Jonathan Kurtis
Malaria: triple artemisinin-based combination therapies safe and effective
Helminthic Infections
Conference report – London Centre for Neglected Tropical Disease Research Anniversary Event
ISNTD – Female Genital Schistosomiasis: The most neglected gynaecological disease
Conference report – British Society for Parasitology Autumn Symposium
Malaria
Malaria parasites resistant to artemisinin now prevalent in Africa
Using a novel approach for malaria vaccine development – an interview with Jonathan Kurtis
Malaria: triple artemisinin-based combination therapies safe and effective
Neglected Tropical Diseases
Novel parasites and understanding parasite–host interactions – an interview with Sandra Maruyama
Mice, introduced by maritime trade, play a key role in Toxoplasma gondii distribution
Protozoan Infections
Malaria: triple artemisinin-based combination therapies safe and effective
World Malaria Report 2019: a focus on pregnant women and children
Imaging study reveals how malaria parasites bypass antimalarial drugs
Viral
Moderna’s COVID-19 vaccine demonstrates 94.5% efficacy
Pfizer and BioNTech's COVID-19 vaccine 90% effective in Phase III trial
Accelerate your COVID-19 bioanalytical research while saving time and reducing cost
Hepatitis
A peek behind the paper – Mohammad K Parvez on coronaviral hepatitis
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Herpes
ASM Microbe: What consequences could lifelong Epstein–Barr virus infection have for the brain?
HR-HPV oral infection rates in England are lower than expected
A peek behind the paper – Lynn Enquist on the lifecycle of alpha herpesvirus